Human Beta Defensins analogs as therapeutic targets for infections

Human Beta Defensins analogs as therapeutic targets for infections


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days

₹ 2,675

Availability: Out of stock


Delivery :

5% Cashback on all Orders paid using MobiKwik Wallet T&C

Free Krispy Kreme Voucher on all Orders paid using UltraCash Wallet T&C
Product Out of Stock Subscription

(Notify me when this product is back in stock)

  • Product Description

Human Beta Defensins (hBDs) are a class of antimicrobial peptides (AMPs) that play an important role both in innate and adaptive immunity: they kill bacteria, viruses and fungi and exert chemotaxis against lymphocytes and monocytes. Thanks to their properties, hBDs represent a target to develop therapeutic molecules. Previously, Scudiero et al. synthesized the wild type hBD1, hBD3 and designed analogs selecting the sequences crucial for the activity. In the present study, we tested the possibility to find a new defensin analog with enhanced properties. The new peptide has the following features: shorter total sequence; presence of the C-terminus portion of hBD3; presence of inner portion of hBD1. We perform antibacterial and antiviral tests on E. coli, P. aeruginosa, E. faecalis and simplex virus type 1. In addition, we investigated two pharmacological properties of these peptides: the stability in human serum and the cytotoxic effects on human cells. Finally, in order to investigate whether defensins interact with human epithelial cells, we labeled peptides with NBD fluorochrome and performed confocal microscopy experiments.

Product Specifications
SKU :COC87262
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-10-08
0 Review(s)